MENU
+Compare
ARDX
Stock ticker: NASDAQ
AS OF
Aug 11 closing price
Price
$5.40
Change
+$0.19 (+3.65%)
Capitalization
1.3B

ARDX Ardelyx Forecast, Technical & Fundamental Analysis

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs... Show more

Industry: #Biotechnology
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARDX with price predictions
Aug 11, 2025

ARDX in upward trend: 10-day moving average moved above 50-day moving average on July 08, 2025

The 10-day moving average for ARDX crossed bullishly above the 50-day moving average on July 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 05, 2025. You may want to consider a long position or call options on ARDX as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARDX just turned positive on August 05, 2025. Looking at past instances where ARDX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARDX advanced for three days, in of 269 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 172 cases where ARDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARDX broke above its upper Bollinger Band on August 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.328) is normal, around the industry mean (18.461). P/E Ratio (0.000) is within average values for comparable stocks, (53.401). ARDX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.822). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (3.328) is also within normal values, averaging (286.886).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARDX is expected to report earnings to rise 5.25% to -8 cents per share on October 30

Ardelyx ARDX Stock Earnings Reports
Q3'25
Est.
$-0.08
Q2'25
Beat
by $0.05
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.05
The last earnings report on August 04 showed earnings per share of -7 cents, beating the estimate of -12 cents. With 3.42M shares outstanding, the current market capitalization sits at 1.30B.
A.I. Advisor
published General Information

General Information

a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSPFX4.50N/A
N/A
US Global Investors Global Res
GILIX21.62-0.04
-0.18%
NAA Large Core Instl
FTHNX46.45-0.10
-0.21%
FullerThaler Behavioral Sm-Cp Eq Inv
AVUGX8.22-0.02
-0.24%
American Century Value R5
PCPAX22.24-0.07
-0.31%
PACE Large Co Value Equity A

ARDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with RIGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
+3.65%
RIGL - ARDX
37%
Loosely correlated
+5.55%
CSCI - ARDX
35%
Loosely correlated
+1.82%
PCVX - ARDX
34%
Loosely correlated
-0.77%
MYNDF - ARDX
33%
Loosely correlated
N/A
CGEN - ARDX
33%
Poorly correlated
N/A
More